相似文献
1
A review of ethical considerations for ventricular assist device placement in older adults.
Aging Dis. 2013 Jan 18;4(2):100-12. Print 2013 Apr.
2
Ethical dilemmas surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunction.
Methodist Debakey Cardiovasc J. 2013 Jan-Mar;9(1):11-4. doi: 10.14797/mdcj-9-1-11.
3
Compassionate deactivation of ventricular assist devices in pediatric patients.
J Heart Lung Transplant. 2016 May;35(5):564-7. doi: 10.1016/j.healun.2016.03.020. Epub 2016 Mar 31.
4
Left ventricular assist devices and other devices for end-stage heart failure: utility of echocardiography.
Curr Cardiol Rep. 2010 May;12(3):257-64. doi: 10.1007/s11886-010-0102-0.
5
Ethical challenges with the left ventricular assist device as a destination therapy.
Philos Ethics Humanit Med. 2008 Aug 11;3:20. doi: 10.1186/1747-5341-3-20.
6
Ethical Considerations in the Long-Term Ventricular Assist Device Patient.
Curr Heart Fail Rep. 2017 Feb;14(1):7-12. doi: 10.1007/s11897-017-0313-4.
7
Responding to Ventricular Assist Device Recalls: An Ethical Guide for Mechanical Circulatory Support Programs.
ASAIO J. 2020 Apr;66(4):363-366. doi: 10.1097/MAT.0000000000001005.
8
Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
Health Technol Assess. 2013 Nov;17(53):1-499, v-vi. doi: 10.3310/hta17530.
9
Ethical challenges of deactivation of cardiac devices in advanced heart failure.
Curr Heart Fail Rep. 2014 Jun;11(2):119-25. doi: 10.1007/s11897-014-0194-8.
10
Compassionate deactivation of ventricular assist devices in children: A survey of pediatric ventricular assist device clinicians' perspectives and practices.
Pediatr Transplant. 2019 May;23(3):e13359. doi: 10.1111/petr.13359. Epub 2019 Feb 7.
引用本文的文献
1
Interdisciplinary Research in Alzheimer's Disease and the Roles International Societies Can Play.
Aging Dis. 2021 Feb 1;12(1):36-41. doi: 10.14336/AD.2020.0602. eCollection 2021 Feb.
2
Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy-Challenges to Measuring Impact and Change in Institutional Culture.
J Pain Symptom Manage. 2017 Aug;54(2):231-236. doi: 10.1016/j.jpainsymman.2016.10.372. Epub 2017 Jan 16.
3
Mechanical circulatory support in the new era: an overview.
Crit Care. 2016 Mar 16;20:66. doi: 10.1186/s13054-016-1235-3.
4
Ventricular assist devices as destination therapy: psychosocial and ethical implications.
Methodist Debakey Cardiovasc J. 2015 Jan-Mar;11(1):9-11. doi: 10.14797/mdcj-11-1-9.
5
Ethical challenges of deactivation of cardiac devices in advanced heart failure.
Curr Heart Fail Rep. 2014 Jun;11(2):119-25. doi: 10.1007/s11897-014-0194-8.
本文引用的文献
1
Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association.
Circulation. 2012 Nov 27;126(22):2648-67. doi: 10.1161/CIR.0b013e3182769a54. Epub 2012 Oct 29.
2
Ramping up evidence-based ventricular assist device care.
J Am Coll Cardiol. 2012 Oct 30;60(18):1776-7. doi: 10.1016/j.jacc.2012.08.978. Epub 2012 Oct 3.
3
Beyond survival: recommendations from INTERMACS for assessing function and quality of life with mechanical circulatory support.
J Heart Lung Transplant. 2012 Nov;31(11):1158-64. doi: 10.1016/j.healun.2012.08.020. Epub 2012 Sep 23.
4
Quality of life and left ventricular assist device support.
Circulation. 2012 Aug 14;126(7):866-74. doi: 10.1161/CIRCULATIONAHA.111.040279.
5
Ethics of the heart: ethical and policy challenges in the treatment of advanced heart failure.
Perspect Biol Med. 2012 Winter;55(1):71-80. doi: 10.1353/pbm.2012.0009.
6
Advance directives in community patients with heart failure.
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):283-9. doi: 10.1161/CIRCOUTCOMES.112.966036.
7
Patient selection for mechanical circulatory support.
Heart Fail Rev. 2013 Jan;18(1):27-34. doi: 10.1007/s10741-012-9316-0.
8
Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
J Am Coll Cardiol. 2012 Jul 3;60(1):44-51. doi: 10.1016/j.jacc.2012.02.032. Epub 2012 Apr 25.
9
Timing isn't everything: donor heart allocation in the present LVAD era.
J Am Coll Cardiol. 2012 Jul 3;60(1):52-3. doi: 10.1016/j.jacc.2012.03.017. Epub 2012 Apr 25.
10
Taking a back seat: support and self-preservation in close relatives of patients with left ventricular assist device.
Eur J Cardiovasc Nurs. 2012 Dec;11(4):380-7. doi: 10.1177/1474515111435609. Epub 2012 Apr 18.
Zotero 插件